Mathangi Krishnamurthy

Title: Mathangi Krishnamurthy: Innovator in Cannabinoid Research

Introduction

Mathangi Krishnamurthy is a prominent inventor based in Memphis, TN (US). She has made significant contributions to the field of cannabinoid research, focusing on the development of cannabinoid derivatives. Her work aims to enhance the understanding and treatment of conditions mediated by cannabinoid receptors.

Latest Patents

Mathangi holds a patent for "Cannabinoid derivatives, methods of making, and use thereof." This patent includes 1'-substituted cannabinoid derivatives of delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, and delta-6a-10a-tetrahydrocannabinol. These compounds exhibit affinity for the cannabinoid receptor type-1 (CB-1) and/or cannabinoid receptor type-2 (CB-2). The compounds can function as either agonists or antagonists of the CB-1 and/or CB-2 receptors, providing potential therapeutic applications for treating conditions related to these receptors.

Career Highlights

Mathangi is affiliated with the University of Tennessee Research Foundation, where she continues her innovative research. Her work has garnered attention for its potential impact on medical treatments involving cannabinoids. She has successfully navigated the complexities of cannabinoid chemistry, contributing to advancements in the field.

Collaborations

Mathangi collaborates with esteemed colleagues, including Bob M Moore, II and Antonio Ferreira. These partnerships enhance her research efforts and contribute to the development of new cannabinoid-based therapies.

Conclusion

Mathangi Krishnamurthy is a trailblazer in cannabinoid research, with a focus on developing innovative solutions for medical applications. Her contributions to the field are paving the way for future advancements in cannabinoid therapies.